Table 3.
Group | Treatment | Hearts with CD45 score ≥2 |
% positive |
Hearts with CD45 score ≥ 3 |
% positive |
p value |
---|---|---|---|---|---|---|
1 | Control mIgG2a | 0/2 | 0% | 0/2 | 0% | |
2 | anti-Kd mIgG2a | 4/7 | 57 | 2/7 | 29 |
0.048 versus
group 1 |
3 | anti-Kd mIgG2a + rPSGL-1 |
0/4 | 0 | 0/4 | 0 |
0.037 versus
group 2 |